World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
97
Citations
31797
World Ranking
830
National Ranking
96

Medicine

D-Index
97
Citations
31849
World Ranking
9348
National Ranking
910

Overview

Gus A. Baker is affiliated with the University of Liverpool in the United Kingdom and has a research focus within the field of Medicine. Their work spans several subfields, including Psychiatry and Mental Health, Pediatrics, Perinatology and Child Health, Cognitive Neuroscience, Genetics, and Neurology.

The primary focus of Baker's research relates to epilepsy, reflected in the topics they have explored such as Epilepsy Research and Treatment, Pharmacological Effects and Toxicity Studies, Psychosomatic Disorders and Their Treatments, Functional Brain Connectivity Studies, Hemoglobinopathies and Related Disorders, Drug Transport and Resistance Mechanisms, and Health Systems, Economic Evaluations, and Quality of Life.

Among recent publications, Baker has contributed to studies published between 2021 and 2024 in notable venues. These works include:

  • The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial, 2021, The Lancet
  • The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial, 2021, The Lancet
  • National plans and awareness campaigns as priorities for achieving global brain health, 2024, The Lancet Global Health
  • Protocol for the development of an international Core Outcome Set for treatment trials in adults with epilepsy: the EPilepsy outcome Set for Effectiveness Trials Project (EPSET), 2022, Trials
  • Development of an International Standard Set of Outcomes and Measurement Methods for Routine Practice for Adults with Epilepsy: The International Consortium for Health Outcomes Measurement Consensus Recommendations, 2024, Epilepsia

Baker frequently collaborates with researchers including Anthony G Marson, Richard Appleton, Melissa Maguire, Donna Walsh, and John Paul Leach.

Their scholarly work is often published in journals that focus on neurological and psychological conditions, with Epilepsia and Epilepsy & Behavior being the most common venues for their publications. Others include The Lancet, Frontiers in Psychology, and bioRxiv (Cold Spring Harbor Laboratory).

Best Publications

  • The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.

    Anthony G Marson;Asya M Al-Kharusi;Muna Alwaidh;Richard Appleton

  • Quality of life of people with epilepsy: a European study.

    Gus A. Baker;Ann Jacoby;Deborah Buck;Carlos Stalgis

  • The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

    Anthony G Marson;Asya M Al-Kharusi;Muna Alwaidh;Richard Appleton

  • Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

    Kimford J Meador;Gus A Baker;Nancy Browning;Morris J Cohen

  • Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs

    Kimford J. Meador;Gus A. Baker;Nancy Browning;Jill Clayton-Smith

  • Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force.

    W. Curt LaFrance;W. Curt LaFrance;Gus A. Baker;Rod Duncan;Laura H. Goldstein

  • The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study.

    Ann Jacoby;Gus A. Baker;Nick Steen;Pauline Potts

  • The longer term outcome of children born to mothers with epilepsy

    N Adab;U Kini;J Vinten;J Ayres

  • Epilepsy and social identity: the stigma of a chronic neurological disorder.

    Ann Jacoby;Dee Snape;Gus A Baker

  • The stigma of epilepsy: a European perspective.

    Gus A. Baker;Jayne Brooks;Debbie Buck;Ann Jacoby

  • Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review.

    Rod S. Taylor;Josemir W. Sander;Rebecca J. Taylor;Gus A. Baker

  • The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs

    Rebecca Louise Bromley;George E Mawer;Maria Briggs;Christopher Cheyne

  • Outcomes of add-on treatment with lamotrigine in partial epilepsy.

    D. Smith;G. Baker;G. Davies;M. Dewey

  • Systematic screening allows reduction of adverse antiepileptic drug effects: A randomized trial

    Frank G. Gilliam;A. J. Fessler;G. Baker;V. Vahle

  • Psychogenic non-epileptic seizures--definition, etiology, treatment and prognostic issues: a critical review.

    N.M.G. Bodde;J.L. Brooks;G.A. Baker;P.A.J.M. Boon

  • In utero antiepileptic drug exposure: Fetal death and malformations

    K. J. Meador;G. A. Baker;Richard Finnell;L. A. Kalayjian

  • Patients' Experiences of Injury as a Result of Epilepsy

    Deborah Buck;Gus A. Baker;Ann Jacoby;David F. Smith

  • Autism spectrum disorders following in utero exposure to antiepileptic drugs.

    R. L. Bromley;G. Mawer;J. Clayton-Smith;G. A. Baker

  • IQ at 6 years after in utero exposure to antiepileptic drugs: A controlled cohort study

    Gus A. Baker;Rebecca L. Bromley;Maria Briggs;Christopher P. Cheyne

  • The psychosocial burden of epilepsy.

    Gus A. Baker

Frequent Co-Authors

Jill Clayton-Smith
Jill Clayton-Smith University of Manchester
Anthony G Marson
Anthony G Marson University of Liverpool
David Chadwick
David Chadwick University of Liverpool
Kimford J. Meador
Kimford J. Meador Stanford University
Joyce Liporace
Joyce Liporace Thomas Jefferson University
Page B. Pennell
Page B. Pennell University of Pittsburgh
David W. Loring
David W. Loring Emory University
Laura H. Goldstein
Laura H. Goldstein King's College London
Albert P. Aldenkamp
Albert P. Aldenkamp Eindhoven University of Technology
Michael Privitera
Michael Privitera University of Cincinnati

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Gus A. Baker

Trending Scientists